Global Contraceptive Market Forecast, Research Findings, Clinical Report & Business Guidelines by Top Companies nclude Bayer AG, Allergan PLC, Merck

Global Contraceptive Market Research Report and Forecast to 2018-2022 Report provides an extensive research on the fast-evolving Contraceptive Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2022.

Contraception, also referred to as birth control, is a method to control unwanted pregnancy. It has been used since ancient times; however, effective contraceptive methods have been introduced in 20th century only. Today, the market is filled with number of contraceptive options providing desirable results and efficacy.

Get Sample PDF of the Contraceptive Market Report at: http://www.orbisresearch.com/contacts/request-sample/2335099

The global contraceptive market is experiencing a robust growth at a lucrative CAGR. Every year, a greater number of people undergoing contraceptive sterilization can be observed. Also, there is a high demand of male condoms due to their affordability, availability and higher efficiency to prevent pregnancy and exposure to sexually transmitted diseases (STDs).

In terms of competition, the global contraceptive market is highly fragmented with a huge number of companies selling generic products. However, the global female contraceptive drug market is dominated by –
• Bayer AG
• Allergan PLC
• Merck & Co.
• Teva Pharmaceuticals

Female contraception drug products are major boosters for the growth of the global contraceptive market. There is a continually growing population of females using hormonal contraception. Oral pills and IUDs are the widely used methods of contraception among females. The global female contraception drug market would continue to move forward with a healthy growth rate in future.

Regionally, the U.S. is the major market for contraceptives due to its increasing female population of childbearing age, higher concentration of key companies, higher awareness of contraceptives and STDs infections, and increasing consumption of female condoms. Also, the desirable size of a family in the U.S. is of two children which supports the consumption of contraceptives in the region. Europe also holds a notable share in the global contraceptive market. However, its share can drop to some extent in future due to decreasing female population of reproductive ages.

Request to Enquire before Buying the Contraceptive Market Report at: http://www.orbisresearch.com/contacts/enquiry-before-buying/2335099

Table of Contents:
1. Overview
1.1 Contraceptive
2. Global Contraceptive Market
2.1 Contraceptive Market Forecast by Value
2.2 Contraceptive Market by Region
2.3 Female Contraceptive Drug Market Forecast by Value
2.4 Female Contraceptive Drug Market by Region
2.5 Female Contraceptive User Volume Forecast
3. Regional Contraceptive Market
3.1 The U.S
3.1.1 The U.S. Contraceptive Market Forecast by Value
3.1.2 The U.S. Contraceptive Market by Type
3.1.3 The U.S. Female Contraceptive Drug Market Forecast by Value
3.1.4 The U.S. Contraceptive Script Volume Forecast
3.1.5 The U.S. Contraceptive Script Volume by Type
3.1.6 The U.S. Female Contraceptive User Volume Forecast
3.2 Europe
3.2.1 Europe Contraceptive Market Forecast by Value
3.2.2 Europe Female Contraceptive Drug Market Forecast by Value
3.2.3 Europe Contraceptive User Volume Forecast
3.2.4 Europe Contraceptive User by Type
3.3 ROW
3.3.1 ROW Contraceptive Market Forecast by Value
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Female Population of Reproductive Ages
4.1.2 Growing Disposable Incomes
4.1.3 Increasing Urban Population
4.2 Key Trends
4.2.1 Unmet Need for Family Planning
4.2.2 Pipeline Programs in Development
4.2.3 Increasing Use of Female Condoms
4.2.4 Increasing Trend of Non-Daily Dosing
4.3 Challenges
4.3.1 Decreasing Fertility Rates
4.3.2 Irregularities in Sex Education
4.3.3 Associated Risks
5. Competition
5.1 Global Market
5.1.1 Revenue Comparison of Key Players
5.1.2 Market Cap Comparison of Key Players
5.1.3 Global Female Contraceptive Drug Market Share by Company
6. Company Profiles
6.1 Bayer
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Merck & Co., Inc.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Teva Pharmaceuticals
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Allergan Plc
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

Browse Complete Contraceptive Market Report at: http://www.orbisresearch.com/reports/index/global-contraceptive-market-industry-analysis-and-outlook-2018-2022

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager — Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas — 75204, U.S.A.
Phone No.: +1 (214) 884–6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.